Efficacy Results of Selective AXL Inhibitor Bemcentinib with Pembrolizumab Following Chemotherapy in Patients with NSCLC

被引：2

作者：

Felip, E. ^{[1
]}

Brunsvig, P. ^{[2
]}

Helland, A. ^{[3
]}

Vinolas, N. ^{[4
]}

Aix, S. ^{[5
]}

Carcereny, E. ^{[6
,7
,8
]}

Domine Gomez, M. ^{[9
]}

Trigo Perez, J. M. ^{[10
]}

Arriola, E. ^{[11
]}

Garcia Campelo, R. ^{[12
]}

Spicer, J. ^{[13
]}

Thompson, J. ^{[14
]}

Ortega Granados, A. L. ^{[15
]}

Holt, R. ^{[16
]}

Smethurst, D. ^{[16
]}

Lorens, J. ^{[16
]}

Shoaib, M. ^{[16
]}

Siddiqui, A. ^{[16
]}

Schoelermann, J. ^{[16
]}

Lorens, K. ^{[16
]}

Schmidt, E. ^{[17
]}

Chisamore, M. J. ^{[18
]}

Krebs, M. ^{[19
,20
]}

机构：

[1] Vall Dhebron Univ Hosp, Barcelona, Spain

[2] Oslo Univ Hosp, Oslo, Norway

[3] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Oslo, Norway

[4] Hosp Clin Barcelona, Barcelona, Spain

[5] Hosp 12 Octubre, Carretera Andalucia, Madrid, Spain

[6] Catalan Inst Oncol Badalona, Med Oncol, Badalona, Spain

[7] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

[8] B Argo, Badalona, Spain

[9] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain

[10] Hosp Virgen de La Victoria, Malaga, Spain

[11] Hosp del Mar, Oncol, Barcelona, Spain

[12] Univ Hosp A Coruna Xxiac Sergas, Med Oncol Serv, La Coruna, Spain

[13] Kings Coll London, Guys Hosp, London, England

[14] Med Coll Wisconsin, Affiliated Hosp, Menomonee Falls, WI USA

[15] Complejo Hosp Jaen, Med Oncol, Jaen, Spain

[16] Bergenbio Asa, Bergen, Norway

[17] Merck & Co Inc, Kenilworth, NJ USA

[18] Merck & Co Inc, Rahway, NJ 07065 USA

[19] Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England

[20] Univ Manchester, Manchester, Lancs, England

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

bemcentinib; AXL; Pembrolizumab;

D O I：

10.1016/j.jtho.2019.08.515

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA03.06

引用

页码：S258 / S259

页数：2